Fig. 3From: Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trialArithmetic mean concentration–time profiles (pre-meal tolerance test) for glucose metabolism parameters in patients with type 2 diabetes mellitus. Data are from the pharmacodynamic analysis setBack to article page